pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    SOT-201
    Solid Tumor SOTIO Biotech AS
  • Phase 1
    SPX-303
    Solid Tumor$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-306
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
← prev
page 34 of 62
next →
Pain89
Neurology1
SPX-308
Unspecified Cancer
$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-602
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-608
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-629
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SRC-3KO Treg Adoptive Cell Therapy
    Glioblastoma Multiforme (GBM) CoRegen Inc
  • Preclinical
    SRC-3KO Treg Allogeneic Cell Therapy
    Solid Tumor CoRegen Inc
  • Phase 1
    ST-01156
    Bile Duct Cancer (Cholangiocarcinoma) Seed Therapeutics Inc
  • Phase 2
    ST316
    Metastatic Bile Duct Cancer Sapience Therapeutics Inc
  • Phase 2
    STK-012
    Non-Small Cell Lung Cancer Synthekine Inc
  • Preclinical
    STP-355
    Breast Cancer Sirnaomics Ltd
  • Preclinical
    STP-369
    Head And Neck Cancer Sirnaomics Ltd
  • Phase 1
    STP-707
    Colorectal Cancer Sirnaomics Ltd
  • Phase 1
    STRO-004
    Cervical Cancer$STRO SUTRO BIOPHARMA, INC.
  • Phase 2
    STX-001
    Melanoma Strand Therapeutics Inc
  • Phase 2
    SV-102
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Syncromune Inc
  • Phase 1
    SW-682
    Malignant Mesothelioma SpringWorks Therapeutics Inc
  • Phase 2
    SY-102
    Refractory Multiple Myeloma Syena
  • Preclinical
    SYD-003
    Pancreatic Cancer Synovo GmbH
  • Phase 1
    SYN-125
    Epithelial Tumor Synermore Biologics Co Ltd
  • Phase 2
    SYS-6002
    Cervical Cancer$CRBP Corbus Pharmaceuticals Holdings, Inc.
  • Preclinical
    Second Shared Cell Therapy
    Unspecified Cancer$ADPT Adaptive Biotechnologies Corp
  • Preclinical
    Small Molecule for Glioblastoma
    Nano Quercetin
    Glioblastoma Multiforme (GBM) Cancer Research and Life Foundation
  • Preclinical
    Small Molecule for Multiple Myeloma
    Multiple Myeloma (Kahler Disease) Sino-American Cancer Foundation
  • Preclinical
    Small Molecule for Osteosarcoma
    Osteosarcoma K-Group Beta Inc
  • Preclinical
    Small Molecule to Inhibit FGL2 for Glioblastoma Multiforme
    Glioblastoma Multiforme (GBM) University of Texas MD Anderson Cancer Center
  • Preclinical
    Small Molecule to Inhibit MAPK13 and MAPK14 for Breast Cancer and Respiratory Disease
    Asthma NuPeak Therapeutics Inc
  • Preclinical
    Small Molecule to Inhibit Monoamine Oxidase Type A for Glioma
    Glioma University of Southern California